Combination of Fractional Carbon Dioxide Laser and Topical Triamcinolone versus Intralesional Triamcinolone for Keloid Treatment

Phase 4

Recruiting

• Conditions: Keloid scar; fractional carbon dioxide laser, intralesional triamcinolone, keloid treatment, topical triamcinolone

• Registration Number: TCTR20211104003
• Lead Sponsor: Faculty of Medicine, Prince of Songkla University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-04
• Study Completion: 2021-11-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Adult patients with keloids

Exclusion Criteria

1.pregnant patients
2.history of herpes zoster infection; an immunocompromised status
3.presence of infections or skin diseases
4.history of steroid and lidocaine allergy
5. history of keloid treatment within the past 1 year

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
scar volume every month within the first 1 year, then every 2 months in the second year. photographic measurement,vascularity, height/thickness, pliability, and pigmentation of the keloid every month within the first 1 year, then every 2 months in the second year. Vancouver Scar Scale score

Secondary Outcome Measures

Name	Time	Method
pain score After intervention was done, every month within the first 1 year 10-cm visual analog scale ,complication every 1 month in first year, and every 2 months in the second year Patient reported outcome, physical examination,Keloid recurrence every 2 months in the second year physical examination